Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.63 |
| ▸ | ALPI | P09923 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | XIAP | P98170 | 1/20 | 0.63 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.47 |
| ▸ | CTSC | P53634 | 1/20 | 0.46 |
| ▸ | LAP3 | P28838 | 3/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.46 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28345408 | 0.83 | SLC7A5 (0.66) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL19193059 | 0.83 | SLC7A5 (0.66) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL9295400 | 0.83 | SLC7A5 (0.66) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL11499279 | 0.81 | SLC7A5 (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| D-Phenylalanine SCHEMBL7366481 | 0.81 | SLC7A5 (0.81) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL13367286 | 0.81 | SLC7A5 (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL14357540 | 0.79 | ALPI (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL5063628 | 0.79 | SLC7A5 (0.92) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL6744985 | 0.79 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL7247735 | 0.79 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1708740-A1 | PROTEASE INHIBITORS FOR THE TREATMENT OF DIGESTIVE PATHOLOGIES | Rytek (FR) | 2006-10-11 | — | — | EP | claimed |
| WO-2005077406-A1 | PROTEASE INHIBITORS FOR THE TREATMENT OF DIGESTIVE PATHOLOGIES | RYTEK (FR) | 2005-08-25 | — | — | WO | claimed |
| US-12030928-B2 | Anti-influenza B virus neuraminidase antibodies and uses thereof | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240091337-A1 | INFLUENZA B VIRUS MUTANTS AND USES THEREFOR | FLUGEN, INC. (US) | 2024-03-21 | — | — | US | disclosed |
| CN-117511844-A | Non-invasive method for generating human nasopharyngeal three-and two-dimensional organoids | 免疫与感染研究中心有限公司 | 2024-02-06 | — | — | CN | disclosed |
| EP-4267610-A1 | COMPOSITION OF PIG POLYCLONAL ANTIBODY FOR ITS USE TO TREAT AND/OR PREVENT ANTIBODY-DEPENDENT MACROPHAGE PRO-INFLAMMATORY CYTOKINE RELEASE IN A PASSIVE ANTI-INFECTIOUS IMMUNOTHERAPY | Xenothera (FR) | 2023-11-01 | — | — | EP | disclosed |
| EP-4205753-A1 | ANTIVIRAL PLANT EXTRACT COMPOSITION AND METHOD FOR PREPARING SUCH COMPOSITION | Cariel, Léon (FR) | 2023-07-05 | — | — | EP | disclosed |
| EP-4205754-A1 | ANTIVIRAL PLANT EXTRACT COMPOSITION AND METHOD FOR PREPARING SUCH COMPOSITION | Cariel, Léon (FR) | 2023-07-05 | — | — | EP | disclosed |
| US-11529409-B2 | Influenza B virus mutants and uses therefor | FLUGEN, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| WO-2022136505-A1 | COMPOSITION OF PIG POLYCLONAL ANTIBODY FOR ITS USE TO TREAT AND/OR PREVENT ANTIBODY-DEPENDENT MACROPHAGE PRO-INFLAMMATORY CYTOKINE RELEASE IN A PASSIVE ANTI-INFECTIOUS IMMUNOTHERAPY | XENOTHERA (FR) | 2022-06-30 | — | — | WO | disclosed |
| US-20220153873-A1 | ANTI-INFLUENZA B VIRUS NEURAMINIDASE ANTIBODIES AND USES THEREOF | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2022-05-19 | — | — | US | disclosed |
| WO-2017183864-A1 | COMPOSITION FOR NOROVIRUS CULTURE AND METHOD FOR NOROVIRUS CULTURE | 전남대학교산학협력단 | 2017-10-26 | — | — | WO | disclosed |
| CN-104780919-A | Composition, containing cis-cyclo(l-leu-l-pro) or cis-cyclo(l-phe-l-pro), for use as an antimicrobial and antiviral agent, and preparation method therefor | SNU R & D FOUNDATION | 2015-07-15 | — | — | CN | disclosed |
| US-20130165489-A1 | Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2013-06-27 | — | — | US | disclosed |
| US-20120010103-A1 | METHODS OF SCREENING USING AMPHIBIANS | BRAENDLI ANDRE W (CH) | 2012-01-12 | — | — | US | disclosed |
| WO-2008136906-A1 | PHOTOSENSITIZERS FOR TARGETED PHOTODYNAMIC THERAPY | THE GENERAL HOSPITAL CORPORATION (US) | 2008-11-13 | — | — | WO | disclosed |
| EP-1708740-A1 | PROTEASE INHIBITORS FOR THE TREATMENT OF DIGESTIVE PATHOLOGIES | Rytek (FR) | 2006-10-11 | — | — | EP | disclosed |
| WO-2005077406-A1 | PROTEASE INHIBITORS FOR THE TREATMENT OF DIGESTIVE PATHOLOGIES | RYTEK (FR) | 2005-08-25 | — | — | WO | disclosed |
| CN-1029131-C | Process for transforming human insulin precarsor to human insulin | LILLY CO ELI (US) | 1995-06-28 | — | — | CN | disclosed |
| CN-87107019-A | Method for converting human insulin precursor into human insulin | — | 1988-04-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165489-A1 | Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof | ZC3HAV1, MAVS, HAVCR2 | SLC7A5 2586/4885ALPI 4751/4885PKM 3784/4885 |
| US-20240091337-A1 | INFLUENZA B VIRUS MUTANTS AND USES THEREFOR | HAVCR2, CMBL, CD81 | SLC7A5 3434/4885ALPI 3557/4885PKM 4752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.